Trying to convince our Minister of Trade and Industry to create better incentiver for startup and founders:-) #timeforchange #startup #politicians

So excited to announce this highly interesting clinical collaboration with Nektar Therapeutics! vaccibody.com/vaccibody-anno…

We’ve entered into a new clinical collaboration with Vaccibody to combine their personalized neo-antigen cancer vaccine with NKTR-214. Learn more about this combination's design to harness specific T cell clonal expansion in the fight against cancer: bit.ly/2xqtkr6

Finansavisen lørdag- hvorfor er Vaccibody og Nektar så gode partnere?

NRK EKKO har laget et flott radioinnslag om vår porteføljebedrift Vaccibody der Agnete B. Fredriksen forteller om hvordan de utvikler persontilpassede kreftvaksiner: radio.nrk.no/serie/ekko#t=5… #helsenæring #kreft

Vaccibody is excited to announce a Collaboration With Roche combining VB10.16 and Atezolizumab in Cervical Cancer! vaccibody.com/vaccibody-as-r…

And then the 230 MNOK was secured! Thanks for the strong support and interest from our investors! vaccibody.com/sucessfully-cl…

In San Francisco speaking at the Mol Med Tri-Con while TV2 tells about our Roche collaboration. Exciting days. tv2.no/nyheter/104662…

🎤 Speaker #1 - We're thrilled to have Agnete Fredriksen Agnete B. Fredriksen, CSO of @Vaccibody, join us at Labiotech Insider Day! Take a sneak peek at the program & register today! 👉🏻 bit.ly/2KHPWLe 👈🏻 #biotech #LBRefresh

Thanks for the invite and opportunity to share my journey. Really enjoyed the entire program and the interactive discussions!

New times in Vaccibody! Thx to Martin for 4 great years! And a warm welcome to Michael! Ready for next phase💪🏼 vaccibody.com/organizational…

Very excited about the strong signs of vaccine-induces clinical responses, backed up with a range of scientificly sound correlations, in our cancer neoantigen vaccine trial! lnkd.in/eP4csKp #cancerresearch #cancervaccine #neoantigens

Proud and excited for reaching this milestone! Rewarding to work with JZ and the rest of the Nektar team.

This is an amazing achievement by the entire Vaccibody family! Thanks to the patients, investigators, collaborators and all Vaccibody team members for the dedication to this important study. vaccibody.com/wp-content/upl…

We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. bit.ly/36uEsEl

Når grundertilværelsen føles ekstra meningsfull🌟 ringvirkninger.dnb.no/vis/990646066

Joining forces with >60 leaders in immunology to encourage FDA to increase the focus on T cell responses in COVID-19 and infectious diseases in general.

Read about our unique personalized cancer therapy in today news

– Vi skreddersyr kreftvaksiner til hver pasient. Vi tar immunterapi ett skritt videre, og bruker kunnskapen til å utvikle enda mer persontilpasset medisin, sier president og grunnlegger av #Vaccibody, Agnete B. Fredriksen, til VG. vg.no/i/6nKj0L

Ny pod er ute nå. Elisabeth Andersen har besøk av Agnete B. Fredriksen og Martin Bonde fra vår porteføljebedrift #Vaccibody: Vi snakker om utviklingen av deres persontilpassede kreftvaksine og planer for framtiden soundcloud.com/user-972208711…